NACCT Planning Committee Announces Virtual Meeting in October 2021
NACCT Main Congress October 16-18, 2021 The NACCT planning committee has made the difficult decision to move from a hybrid congress to an all-virtual format. The decision was difficult, but with speakers, moderators and poster presenters unable to travel due to the threat of COVID-19…
Next AACT Section Webinar scheduled for September 9, 2021 at 1:00 pm Eastern
AACT Mobile App Available
AACT’s mobile app serves as AACT’s hub for content, collaboration and events all year around. The App gives you access to your AACT colleagues and puts exclusive content at your fingertips. AACT’s app will enable you to: Stay up-to-date on AACT news, Question of the…
New Tox Coach Program is Accepting Applications for Mentees and Mentors
AACT’s new ToxCoach Program is recruiting mentees and mentors to participate in the program. Apply today! Sign up for ToxCoach
Seeking Volunteers to help plan Half Day pre-ACMT program.
AACT is planning a half day of content just prior to ACMTs 2022 Annual Scientific Meeting. The planning committee is looking for volunteers to work with the Scientific Committee to determine content and recruit speakers. The Scientific Committee is co-chaired by Dr. Jon Cole and…
Important Announcement Regarding NACCT 2021
Dear Friends and Colleagues, The American Academy of Clinical Toxicology (AACT) Board of Trustees and the American Association of Poison Control Centers (AAPCC) Executive Committee have agreed to develop a “hybrid” meeting of the North American Congress of Clinical Toxicology (NACCT). This means there will be…
AACT, AAPCC and ACMT Release Joint Statement of Caution Regarding Use of Colchicine for Treatment of COVID-19
Joint Statement of Caution on Colchicine
AACT Signs On to Letter Advocating Increased Patient Access to Buprenorphine
Together with fourteen other organizations, the AACT signed this letter to the Health and Human Services Acting Secretary. Sign-on letter to Acting Secretary Cochran on Practice Guidelines for Prescribing Buprenorphine – 01.27.21